1. Home
  2. CVE vs INSM Comparison

CVE vs INSM Comparison

Compare CVE & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVE
  • INSM
  • Stock Information
  • Founded
  • CVE 2009
  • INSM 1988
  • Country
  • CVE Canada
  • INSM United States
  • Employees
  • CVE 7150
  • INSM N/A
  • Industry
  • CVE Oil & Gas Production
  • INSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVE Energy
  • INSM Health Care
  • Exchange
  • CVE Nasdaq
  • INSM Nasdaq
  • Market Cap
  • CVE 31.3B
  • INSM 29.0B
  • IPO Year
  • CVE N/A
  • INSM 2000
  • Fundamental
  • Price
  • CVE $17.72
  • INSM $161.88
  • Analyst Decision
  • CVE Strong Buy
  • INSM Strong Buy
  • Analyst Count
  • CVE 3
  • INSM 19
  • Target Price
  • CVE $23.33
  • INSM $152.71
  • AVG Volume (30 Days)
  • CVE 26.4M
  • INSM 2.2M
  • Earning Date
  • CVE 10-30-2025
  • INSM 10-30-2025
  • Dividend Yield
  • CVE 3.07%
  • INSM N/A
  • EPS Growth
  • CVE N/A
  • INSM N/A
  • EPS
  • CVE 1.05
  • INSM N/A
  • Revenue
  • CVE $38,310,383,744.00
  • INSM $398,105,000.00
  • Revenue This Year
  • CVE N/A
  • INSM $32.44
  • Revenue Next Year
  • CVE N/A
  • INSM $123.99
  • P/E Ratio
  • CVE $16.87
  • INSM N/A
  • Revenue Growth
  • CVE N/A
  • INSM 21.15
  • 52 Week Low
  • CVE $10.23
  • INSM $60.40
  • 52 Week High
  • CVE $18.18
  • INSM $163.22
  • Technical
  • Relative Strength Index (RSI)
  • CVE 54.40
  • INSM 80.92
  • Support Level
  • CVE $16.59
  • INSM $156.87
  • Resistance Level
  • CVE $17.55
  • INSM $148.22
  • Average True Range (ATR)
  • CVE 0.48
  • INSM 4.33
  • MACD
  • CVE -0.09
  • INSM 0.79
  • Stochastic Oscillator
  • CVE 35.02
  • INSM 98.84

About CVE Cenovus Energy Inc

Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 786 thousand barrels of oil equivalent per day in 2022. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: